Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Polydex Pharmaceuticals (NasdaqSC:POLXF)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Financials
Recent Events
Aug 31Price hit new 52-week low ($2.50)
Location
421 Comstock Road, Toronto
Ontario M1L 2H5, Canada
Phone: (416) 755-2231
Fax: (416) 755-0334
Email: linda@northarm.com
Employees (last reported count): 86
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 34%
·Institutional: 0% (0% of float)
(one institution)
·Net Inst. Buying: 8,000  shares (+50.03%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Polydex Pharmaceuticals Limited, through its subsidiaries, manufactures and sells Dextran and several of its derivatives, including Iron Dextran and Dextran Sulphate, veterinary pharmaceutical products and other specialty chemicals and cosmetic raw materials, with some related research and development. The Company is investigating the potential human applications of some of its products. Iron Dextran is a derivative of Dextran, produced by complexing Iron with Dextran. Iron extran is injected into most pigs at birth as a treatment for anemia. Dextran Sulphate is a specialty chemical that finds use in research applications of the pharmaceutical industry and other centers of chemical research. The Company also manufactures sterile injectable products, tablets and boluses, internal and external solutions, ointments and powders.
More from Market Guide: Expanded Business Description

Financial Summary
Polydex Pharmaceuticals, through the Company 's subsidiaries, is engaged in the manufacturing and sale of veterinary pharmaceutical products and specialty chemicals. For the three months ended 4/30/01, revenues fell 10% to $3.1 million. Net loss totaled $65 thousand, vs. an income of $80 thousand. Revenues reflect decreased sales in the injectable product line. Net loss also reflects higher average costs for fixed manufacturing overheads and increased R&D expenses.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

George Usher, 42
Chairman, Pres and CEO
$135K
Thomas Usher, 86
Vice Chairman
220K
Sharon Wardlaw, 48
CFO, Sec. and Treasurer
--  
Dollar amounts are as of 31-Jan-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:POLXFAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$2.50 
Recent Price$2.50 
52-Week High
on 5-Sep-2000
$6.688
Beta1.66 
Daily Volume (3-month avg)1,636 
Daily Volume (10-day avg)2,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-60.0%
52-Week Change
relative to S&P500
-46.3%
Share-Related Items
Market Capitalization$7.57M
Shares Outstanding3.03M
Float2.00M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 10 on 23-June-1997
Per-Share Data
Book Value (mrq)$2.25 
Earnings (ttm)-$0.01 
Earnings (mrq)-$0.02 
Sales (ttm)$4.38 
Cash (mrq)$0.05 
Valuation Ratios
Price/Book (mrq)1.11 
Price/EarningsN/A 
Price/Sales (ttm)0.57 
Income Statements
Sales (ttm)$13.5M
EBITDA (ttm)$666.0K
Income available to common (ttm)-$13.0K
Profitability
Profit Margin (ttm)-0.1%
Operating Margin (ttm)-1.5%
Fiscal Year
Fiscal Year EndsJan 31
Most recent quarter30-Apr-2001
Management Effectiveness
Return on Assets (ttm)-0.12%
Return on Equity (ttm)-0.19%
Financial Strength
Current Ratio (mrq)1.74 
Debt/Equity (mrq)0.36 
Total Cash (mrq)$145.0K
Short Interest
As of 8-Aug-2001
Shares Short2,000 
Percent of Float0.1%
Shares Short
(Prior Month)
0 
Short Ratio2.00 
Daily Volume1,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.